Company / Free Cash Flow
Immunocore Holdings plc Free Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$15.1M
FY2025
5-year range
-$144.5M / $20.9M
FY2021-FY2025
Trend
-172.1%
vs FY2024
Sector context
#71 of 194
Health Care
What the data says
At -$15M, Immunocore Holdings plc's free cash flow ranks #71 of 194 in the Health Care sector. Declined from -$2M to -$15M over the past 2 years.
Based on SEC 10-K filings.
-$15M in FY2025.
Declined from -$2M to -$15M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#71 of 194 in Health CareTop 37% of 194This company -$15.1M Sector average $470.6M
▼
-103.2% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 172.1% year-over-year.
- Ranks #71 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$15.1M | -172.1% |
| FY2024 | $20.9M | +940.6% |
| FY2023 | -$2.5M | +95.2% |
| FY2022 | -$51.4M | +64.4% |
| FY2021 | -$144.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026